Health Condition 1: N529- Male erectile dysfunction, unspecified
Conditions
Interventions
Intervention1: Tablet Avanafil 100mg: Patients presenting with Erecttile Dysfunction for their evaluation will be given 100mg Oral Avanafil and Erection Hardness Score will be evaluated after 15-20 mi
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: All patients presenting to our OPD with ED of more than 1 month, Irrespective of marital status, comorbidities shall be further evaluated with International Index of Erectile Function (IIEF-5) questionnaire and for all relevant medical and sexual history. Only patients with EHS 1 or 2 based on history will be included in the study
Exclusion criteria
Exclusion criteria: 1. Tried PDE5 inhibitors in the past and had discontinued either due to significant side-effects, or had known hypersensitivity to PDE5 inhibitors; 2. Patients with history of primary hypoactive sexual desire, hypogonadism(serum total testosterone levels less than 300ng/dL) 3. spinal cord injury, 4. pelvic surgery and radical prostatectomy; 5. History of or predisposition to priapism; presence of penile anatomical abnormalities; and use of penile implants. 6. Penile surgery other than circumcision. 7. EHS 0 or EHS 3,4.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Side effectsTimepoint: Upto 24-48 hours | — |
Primary
| Measure | Time frame |
|---|---|
| Improvement in Erection Hardness Score from BaselineTimepoint: 30 minutes | — |
Countries
India
Contacts
Public ContactDr Manish Kumar
Sri Narayani Hospital and Research Centre
Outcome results
None listed